The global acne treatment market is anticipated to grow at a CAGR 4.8% during the forecast period 2020-2026.

Acne is also known as acne vulgaris. It is a condition which occurs because of clogging of the hair follicles with dead skin cells or oil. Its symptoms include pustules, cystic lesions, nodules, and papules, among others.

Factors such as high prevalence of acne, rising teenage population, and growing number of cosmetic surgeries are expected to drive the market growth. According to the American Society for Aesthetic Plastic Surgery, spending on aesthetic procedures in 2016 was USD 13.5 billion. Furthermore, increasing awareness regarding the treatment options of acne is also expected to positively affect the market growth.

However, reported side effects of the non-prescription acne care products and high cost of therapeutic procedures such as microdermabrasion and dermabrasion is expected to negatively impact the market growth during the forecast period.

Segmentation:

The global acne treatment market is segmented by type, treatment, treatment modality, and end user.

On the basis of type, the market is segmented into comedonal acne, inflammatory acne, cystic acne, post-surgical/wound acne, and others.

Based upon the treatment, the market is classified into medication, therapeutic devices, and others. The medication segment is further divided into retinoid, antibiotics, and others. The retinoid segment is further segmented into adapalene, tretinoin, and others. The antibiotics segment is further classified into erythromycin, clindamycin, and others. The therapeutic devices segment is further sub segmented into lasers, microdermabrader, dermabradors, and others.

On the basis of treatment modality, the market is segmented into oral, topical, and injectable.

Based on the end users, the market is segmented into hospitals & clinics, pharmacies & drug stores, ambulatory surgery centers, and others.

Regional Analysis:

By region, the global acne treatment market is segmented into the North America, Europe, Asia-Pacific, and LAMEA.

North America is estimated to lead the global market in 2019, owing to the increasing consciousness amongst the people regarding their facial appearance.The Europe market is expected to garner significant market share owing to the rising teenage population and availability of funds from research.The acne treatment market is the Asia-Pacific region is anticipated to grow at the fastest CAGR owing to presence of major players in the region. The market in LAMEA is expected to slowly grow owing to the stringent government regulations and presence of poor economies.

Competitive Landscape:

The major players profiled in the report include Allergan (Republic of Ireland), Galderma S.A. (Switzerland), Stiefel Laboratories, Inc. (US), Bausch Health (Canada), Johnson & Johnson Services, Inc. (US), GlaxoSmithKline Plc (UK), Teva Pharmaceutical Industries Ltd (Israel), Bayer  AG (Germany), and F. Hoffmann-La Roche Ltd (Switzerland), among others.

The companies are investing in partnerships, acquisitions, and product launc to the growth of the market. For instance, in October 2018, Allergan announced that its subsdiary Almirall Laboratorie have received product approval for its new drug name SeySara (US) for the treatment of patients suffering from COVID 19. Such developments are expected to garner the largest market share and the fastest CAGR too.